Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 5th edition, 486 pages

Free download


  COVID-19

  Free Subscription


Articles published in Lancet Infect Dis

Retrieve available abstracts of 229 articles:
HTML format



Single Articles


    November 2020
  1. BAR-ZEEV N, Kochhar S
    Expecting the unexpected with COVID-19 vaccines.
    Lancet Infect Dis. 2020 Nov 17. pii: S1473-3099(20)30870.
    PubMed    


  2. ZHANG Y, Zeng G, Pan H, Li C, et al
    Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial.
    Lancet Infect Dis. 2020 Nov 17. pii: S1473-3099(20)30843.
    PubMed     Abstract available


  3. PEIFFER-SMADJA N, Rebeaud ME, Guihur A, Mahamat-Saleh Y, et al
    Hydroxychloroquine and COVID-19: a tale of populism and obscurantism.
    Lancet Infect Dis. 2020 Nov 13. pii: S1473-3099(20)30866.
    PubMed    


  4. NG OT, Marimuthu K, Koh V, Pang J, et al
    SARS-CoV-2 seroprevalence and transmission risk factors among high-risk close contacts: a retrospective cohort study.
    Lancet Infect Dis. 2020 Nov 2. pii: S1473-3099(20)30833.
    PubMed     Abstract available


  5. BADR HS, Gardner LM
    Limitations of using mobile phone data to model COVID-19 transmission in the USA.
    Lancet Infect Dis. 2020 Nov 2. pii: S1473-3099(20)30861.
    PubMed    


    October 2020
  6. IVERSEN K, Bundgaard H, Harritshoj L, Ullum H, et al
    Specificity and cross-reactivity of a test for anti-SARS-CoV-2 antibodies - Authors' reply.
    Lancet Infect Dis. 2020 Oct 30. pii: S1473-3099(20)30849.
    PubMed    


  7. CHOY KW
    Specificity and cross-reactivity of a test for anti-SARS-CoV-2 antibodies.
    Lancet Infect Dis. 2020 Oct 30. pii: S1473-3099(20)30787.
    PubMed    


  8. VAN ELSLANDE J, Andre E, Van Ranst M, Lagrou K, et al
    Immunoassays for anti-SARS-CoV-2 antibodies: recent insights.
    Lancet Infect Dis. 2020 Oct 30. pii: S1473-3099(20)30846.
    PubMed    


  9. HODGSON SH, Mansatta K, Mallett G, Harris V, et al
    What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2.
    Lancet Infect Dis. 2020 Oct 27. pii: S1473-3099(20)30773.
    PubMed     Abstract available


  10. YANG W, Kandula S, Huynh M, Greene SK, et al
    Estimating the infection-fatality risk of SARS-CoV-2 in New York City during the spring 2020 pandemic wave: a model-based analysis.
    Lancet Infect Dis. 2020 Oct 19. pii: S1473-3099(20)30769.
    PubMed     Abstract available


  11. BROWN RCH, Kelly D, Wilkinson D, Savulescu J, et al
    The scientific and ethical feasibility of immunity passports.
    Lancet Infect Dis. 2020 Oct 16. pii: S1473-3099(20)30766.
    PubMed     Abstract available


  12. ISAKOVA-SIVAK I, Rudenko L
    A promising inactivated whole-virion SARS-CoV-2 vaccine.
    Lancet Infect Dis. 2020 Oct 15. pii: S1473-3099(20)30832.
    PubMed    


  13. XIA S, Zhang Y, Wang Y, Wang H, et al
    Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial.
    Lancet Infect Dis. 2020 Oct 15. pii: S1473-3099(20)30831.
    PubMed     Abstract available


  14. TILLETT RL, Sevinsky JR, Hartley PD, Kerwin H, et al
    Genomic evidence for reinfection with SARS-CoV-2: a case study.
    Lancet Infect Dis. 2020 Oct 12. pii: S1473-3099(20)30764.
    PubMed     Abstract available


  15. IWASAKI A
    What reinfections mean for COVID-19.
    Lancet Infect Dis. 2020 Oct 12. pii: S1473-3099(20)30783.
    PubMed    


  16. VEHRESCHILD MJGT, Tacconelli E, Giske CG, Peschel A, et al
    Beyond COVID-19-a paradigm shift in infection management?
    Lancet Infect Dis. 2020 Oct 9. pii: S1473-3099(20)30789.
    PubMed    


  17. THE LANCET INFECTIOUS DISEASES
    The intersection of COVID-19 and mental health.
    Lancet Infect Dis. 2020 Oct 8. pii: S1473-3099(20)30797.
    PubMed    


  18. BURKI T
    China's successful control of COVID-19.
    Lancet Infect Dis. 2020 Oct 8. pii: S1473-3099(20)30800.
    PubMed    


  19. PERLMAN S, Zumla A
    MERS-CoV in Africa-an enigma with relevance to COVID-19.
    Lancet Infect Dis. 2020 Oct 6. pii: S1473-3099(20)30578.
    PubMed    


  20. MOK CKP, Zhu A, Zhao J, Lau EHY, et al
    T-cell responses to MERS coronavirus infection in people with occupational exposure to dromedary camels in Nigeria: an observational cohort study.
    Lancet Infect Dis. 2020 Oct 6. pii: S1473-3099(20)30599.
    PubMed     Abstract available


  21. KHALIL A, von Dadelszen P, Kalafat E, Sebghati M, et al
    Change in obstetric attendance and activities during the COVID-19 pandemic.
    Lancet Infect Dis. 2020 Oct 5. pii: S1473-3099(20)30779.
    PubMed    


  22. GALVAO J
    COVID-19: the deadly threat of misinformation.
    Lancet Infect Dis. 2020 Oct 5. pii: S1473-3099(20)30721.
    PubMed    


  23. BURKI T
    COVID-19 claims another victim.
    Lancet Infect Dis. 2020;20:1129-1130.
    PubMed    


  24. MAKONI M
    COVID-19 in Africa: half a year later.
    Lancet Infect Dis. 2020;20:1127.
    PubMed    


  25. RATHI S, Ish P, Kalantri A, Kalantri S, et al
    Hydroxychloroquine prophylaxis for COVID-19 contacts in India.
    Lancet Infect Dis. 2020;20:1118-1119.
    PubMed    


  26. PRINCIPI N, Esposito S
    Chloroquine or hydroxychloroquine for prophylaxis of COVID-19.
    Lancet Infect Dis. 2020;20:1118.
    PubMed    


  27. KIRBY T
    Evelina Tacconelli-two viruses, two wars.
    Lancet Infect Dis. 2020;20:1132.
    PubMed    


  28. BALAKRISHNAN VS
    The arrival of Sputnik V.
    Lancet Infect Dis. 2020;20:1128.
    PubMed    


    September 2020
  29. FRANCO-PAREDES C, Ghandnoosh N, Latif H, Krsak M, et al
    Decarceration and community re-entry in the COVID-19 era.
    Lancet Infect Dis. 2020 Sep 29. pii: S1473-3099(20)30730.
    PubMed     Abstract available


  30. MONDELLI MU, Colaneri M, Seminari EM, Baldanti F, et al
    Low risk of SARS-CoV-2 transmission by fomites in real-life conditions.
    Lancet Infect Dis. 2020 Sep 29. pii: S1473-3099(20)30678.
    PubMed    



  31. Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison.
    Lancet Infect Dis. 2020 Sep 23. pii: S1473-3099(20)30634.
    PubMed     Abstract available


  32. HOULIHAN CF, Beale R
    The complexities of SARS-CoV-2 serology.
    Lancet Infect Dis. 2020 Sep 23. pii: S1473-3099(20)30699.
    PubMed    


  33. TEBOH-EWUNGKEM MI, Ngwa GA
    COVID-19 in malaria-endemic regions: potential consequences for malaria intervention coverage, morbidity, and mortality.
    Lancet Infect Dis. 2020 Sep 21. pii: S1473-3099(20)30763.
    PubMed    


  34. WEISS DJ, Bertozzi-Villa A, Rumisha SF, Amratia P, et al
    Indirect effects of the COVID-19 pandemic on malaria intervention coverage, morbidity, and mortality in Africa: a geospatial modelling analysis.
    Lancet Infect Dis. 2020 Sep 21. pii: S1473-3099(20)30700.
    PubMed     Abstract available


  35. GATALO O, Tseng K, Hamilton A, Lin G, et al
    Associations between phone mobility data and COVID-19 cases.
    Lancet Infect Dis. 2020 Sep 15. pii: S1473-3099(20)30725.
    PubMed    


  36. RHODES A, Hoq M, Measey MA, Danchin M, et al
    Intention to vaccinate against COVID-19 in Australia.
    Lancet Infect Dis. 2020 Sep 14. pii: S1473-3099(20)30724.
    PubMed    


  37. BAX A, Bax CE, Stadnytskyi V, Anfinrud P, et al
    SARS-CoV-2 transmission via speech-generated respiratory droplets.
    Lancet Infect Dis. 2020 Sep 11. pii: S1473-3099(20)30726.
    PubMed    


  38. THE LANCET INFECTIOUS DISEASES
    Curing COVID-19.
    Lancet Infect Dis. 2020 Sep 10. pii: S1473-3099(20)30706.
    PubMed    


  39. THE LANCET INFECTIOUS DISEASES
    Air travel in the time of COVID-19.
    Lancet Infect Dis. 2020;20:993.
    PubMed    


  40. BURKI T
    The origin of SARS-CoV-2.
    Lancet Infect Dis. 2020;20:1018-1019.
    PubMed    


  41. YELIN D, Wirtheim E, Vetter P, Kalil AC, et al
    Long-term consequences of COVID-19: research needs.
    Lancet Infect Dis. 2020 Sep 1. pii: S1473-3099(20)30701.
    PubMed    


    August 2020
  42. GRASSLY NC, Pons-Salort M, Parker EPK, White PJ, et al
    Comparison of molecular testing strategies for COVID-19 control: a mathematical modelling study.
    Lancet Infect Dis. 2020 Aug 18. pii: S1473-3099(20)30630.
    PubMed     Abstract available


  43. JIANG L, Tang K, Levin M, Irfan O, et al
    COVID-19 and multisystem inflammatory syndrome in children and adolescents.
    Lancet Infect Dis. 2020 Aug 17. pii: S1473-3099(20)30651.
    PubMed     Abstract available


  44. JAVELLE E, Raoult D
    COVID-19 pandemic more than a century after the Spanish flu.
    Lancet Infect Dis. 2020 Aug 11. pii: S1473-3099(20)30650.
    PubMed    


  45. HEATH PT, Le Doare K, Khalil A
    Inclusion of pregnant women in COVID-19 vaccine development.
    Lancet Infect Dis. 2020 Aug 11. pii: S1473-3099(20)30638.
    PubMed    


  46. MANHEIM D
    Evolving ethics of COVID-19 challenge trials.
    Lancet Infect Dis. 2020 Aug 11. pii: S1473-3099(20)30649.
    PubMed    


  47. STANDL F, Jockel KH, Brune B, Schmidt B, et al
    Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics.
    Lancet Infect Dis. 2020 Aug 11. pii: S1473-3099(20)30648.
    PubMed    


  48. GARDNER L, Ratcliff J, Dong E, Katz A, et al
    A need for open public data standards and sharing in light of COVID-19.
    Lancet Infect Dis. 2020 Aug 10. pii: S1473-3099(20)30635.
    PubMed    


  49. EPSTEIN JB, Chow K, Mathias R
    Dental procedure aerosols and COVID-19.
    Lancet Infect Dis. 2020 Aug 10. pii: S1473-3099(20)30636.
    PubMed    


  50. KALK A, Schultz A
    SARS-CoV-2 epidemic in African countries-are we losing perspective?
    Lancet Infect Dis. 2020 Aug 7. pii: S1473-3099(20)30563.
    PubMed    


  51. HEYWOOD AE, Macintyre CR
    Elimination of COVID-19: what would it look like and is it possible?
    Lancet Infect Dis. 2020 Aug 6. pii: S1473-3099(20)30633.
    PubMed    


  52. ARORA RK, Joseph A, Van Wyk J, Rocco S, et al
    SeroTracker: a global SARS-CoV-2 seroprevalence dashboard.
    Lancet Infect Dis. 2020 Aug 4. pii: S1473-3099(20)30631.
    PubMed    


  53. JOY M, Hobbs FDR, McGagh D, Akinyemi O, et al
    Excess mortality from COVID-19 in an English sentinel network population.
    Lancet Infect Dis. 2020 Aug 4. pii: S1473-3099(20)30632.
    PubMed    


  54. IVERSEN K, Bundgaard H, Hasselbalch RB, Kristensen JH, et al
    Risk of COVID-19 in health-care workers in Denmark: an observational cohort study.
    Lancet Infect Dis. 2020 Aug 3. pii: S1473-3099(20)30589.
    PubMed     Abstract available


  55. KUCHARSKI AJ, Nilles EJ
    Using serological data to understand unobserved SARS-CoV-2 risk in health-care settings.
    Lancet Infect Dis. 2020 Aug 3. pii: S1473-3099(20)30579.
    PubMed    


  56. BURKI T
    The indirect impact of COVID-19 on women.
    Lancet Infect Dis. 2020;20:904-905.
    PubMed    


  57. JESUDASON T
    New WHO road map for NTD recovery post COVID-19.
    Lancet Infect Dis. 2020;20:902.
    PubMed    


  58. KIRBY T
    Annelies Wilder-Smith.
    Lancet Infect Dis. 2020;20:907.
    PubMed    


  59. BARBER S
    Death by racism.
    Lancet Infect Dis. 2020;20:903.
    PubMed    


    July 2020
  60. DAWOOD FS, Ricks P, Njie GJ, Daugherty M, et al
    Observations of the global epidemiology of COVID-19 from the prepandemic period using web-based surveillance: a cross-sectional analysis.
    Lancet Infect Dis. 2020 Jul 29. pii: S1473-3099(20)30581.
    PubMed     Abstract available


  61. GRILLO F, Barisione E, Ball L, Mastracci L, et al
    Lung fibrosis: an undervalued finding in COVID-19 pathological series.
    Lancet Infect Dis. 2020 Jul 28. pii: S1473-3099(20)30582.
    PubMed    


  62. PEELING RW, Boeras D, Wilder-Smith A, Sall A, et al
    Need for sustainable biobanking networks for COVID-19 and other diseases of epidemic potential.
    Lancet Infect Dis. 2020 Jul 24. pii: S1473-3099(20)30461.
    PubMed     Abstract available


  63. BIELICKI JA, Duval X, Gobat N, Goossens H, et al
    Monitoring approaches for health-care workers during the COVID-19 pandemic.
    Lancet Infect Dis. 2020 Jul 23. pii: S1473-3099(20)30458.
    PubMed     Abstract available


  64. THE LANCET INFECTIOUS DISEASES
    The COVID-19 infodemic.
    Lancet Infect Dis. 2020 Jul 17. pii: S1473-3099(20)30565.
    PubMed    


  65. COOK M
    Potential factors linked to high COVID-19 death rates in British minority ethnic groups.
    Lancet Infect Dis. 2020 Jul 17. pii: S1473-3099(20)30583.
    PubMed    


  66. PEELING RW, Wedderburn CJ, Garcia PJ, Boeras D, et al
    Serology testing in the COVID-19 pandemic response.
    Lancet Infect Dis. 2020 Jul 17. pii: S1473-3099(20)30517.
    PubMed     Abstract available


  67. EBERHARDT JN, Breuckmann NP, Eberhardt CS
    Challenges and issues of SARS-CoV-2 pool testing.
    Lancet Infect Dis. 2020 Jul 14. pii: S1473-3099(20)30467.
    PubMed    


  68. BEHRMANN O, Spiegel M
    COVID-19: from rapid genome sequencing to fast decisions.
    Lancet Infect Dis. 2020 Jul 14. pii: S1473-3099(20)30580.
    PubMed    


  69. LOHSE S, Pfuhl T, Berko-Gottel B, Gartner B, et al
    Challenges and issues of SARS-CoV-2 pool testing - Authors' reply.
    Lancet Infect Dis. 2020 Jul 14. pii: S1473-3099(20)30455.
    PubMed    


  70. PEREZ-SAEZ J, Lauer SA, Kaiser L, Regard S, et al
    Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland.
    Lancet Infect Dis. 2020 Jul 14. pii: S1473-3099(20)30584.
    PubMed    


  71. MISHRA B, Behera B, Mohanty M, Ravindra A, et al
    Challenges and issues of SARS-CoV-2 pool testing.
    Lancet Infect Dis. 2020 Jul 14. pii: S1473-3099(20)30463.
    PubMed    


  72. MEREDITH LW, Hamilton WL, Warne B, Houldcroft CJ, et al
    Rapid implementation of SARS-CoV-2 sequencing to investigate cases of health-care associated COVID-19: a prospective genomic surveillance study.
    Lancet Infect Dis. 2020 Jul 14. pii: S1473-3099(20)30562.
    PubMed     Abstract available


  73. LEE J, Kim SY, Sung H, Lee SW, et al
    Challenges and issues of SARS-CoV-2 pool testing.
    Lancet Infect Dis. 2020 Jul 14. pii: S1473-3099(20)30516.
    PubMed    


  74. MEI Q, Li J, Du R, Yuan X, et al
    Assessment of patients who tested positive for COVID-19 after recovery.
    Lancet Infect Dis. 2020 Jul 6. pii: S1473-3099(20)30433.
    PubMed    


  75. GOLDMAN E
    Exaggerated risk of transmission of COVID-19 by fomites.
    Lancet Infect Dis. 2020 Jul 3. pii: S1473-3099(20)30561.
    PubMed    


  76. HOXHA A, Wyndham-Thomas C, Klamer S, Dubourg D, et al
    Asymptomatic SARS-CoV-2 infection in Belgian long-term care facilities.
    Lancet Infect Dis. 2020 Jul 3. pii: S1473-3099(20)30560.
    PubMed    


  77. PETERSEN E, Koopmans M, Go U, Hamer DH, et al
    Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics.
    Lancet Infect Dis. 2020 Jul 3. pii: S1473-3099(20)30484.
    PubMed     Abstract available


  78. SIKKEMA RS, Pas SD, Nieuwenhuijse DF, O'Toole A, et al
    COVID-19 in health-care workers in three hospitals in the south of the Netherlands: a cross-sectional study.
    Lancet Infect Dis. 2020 Jul 2. pii: S1473-3099(20)30527.
    PubMed     Abstract available


  79. BALAKRISHNAN VS
    COVID-19: Playing away the pandemic.
    Lancet Infect Dis. 2020;20:792.
    PubMed    


  80. VENKATESAN P
    COVID-19 in Iran: round 2.
    Lancet Infect Dis. 2020;20:784.
    PubMed    


  81. TRIUNFOL M
    High COVID-19 testing rate in Portugal.
    Lancet Infect Dis. 2020;20:783.
    PubMed    


  82. BAGCCHI S
    Stigma during the COVID-19 pandemic.
    Lancet Infect Dis. 2020;20:782.
    PubMed    


  83. BADR HS, Du H, Marshall M, Dong E, et al
    Association between mobility patterns and COVID-19 transmission in the USA: a mathematical modelling study.
    Lancet Infect Dis. 2020 Jul 1. pii: S1473-3099(20)30553.
    PubMed     Abstract available


  84. AZMAN AS, Luquero FJ
    From China: hope and lessons for COVID-19 control.
    Lancet Infect Dis. 2020;20:756-757.
    PubMed    


  85. ZHANG J, Litvinova M, Wang W, Wang Y, et al
    Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study.
    Lancet Infect Dis. 2020;20:793-802.
    PubMed     Abstract available


  86. JIA Z, Lu Z
    Modelling COVID-19 transmission: from data to intervention.
    Lancet Infect Dis. 2020;20:757-758.
    PubMed    


  87. NIEHUS R, De Salazar PM, Taylor AR, Lipsitch M, et al
    Using observational data to quantify bias of traveller-derived COVID-19 prevalence estimates in Wuhan, China.
    Lancet Infect Dis. 2020;20:803-808.
    PubMed     Abstract available


  88. AHMED H, Allaf M, Elghazaly H
    COVID-19 and medical education.
    Lancet Infect Dis. 2020;20:777-778.
    PubMed    


  89. BAUD D, Nielsen-Saines K, Qi X, Musso D, et al
    Authors' reply.
    Lancet Infect Dis. 2020;20:775-776.
    PubMed    


  90. BURKI T
    Global shortage of personal protective equipment.
    Lancet Infect Dis. 2020;20:785-786.
    PubMed    



  91. Global outbreak research: harmony not hegemony.
    Lancet Infect Dis. 2020;20:770-772.
    PubMed    


    June 2020
  92. DODD RH, Cvejic E, Bonner C, Pickles K, et al
    Willingness to vaccinate against COVID-19 in Australia.
    Lancet Infect Dis. 2020 Jun 30. pii: S1473-3099(20)30559.
    PubMed    


  93. ABBAS M, Pittet D
    Surfing the COVID-19 scientific wave.
    Lancet Infect Dis. 2020 Jun 30. pii: S1473-3099(20)30558.
    PubMed    


  94. SARDANELLI F, Cozzi A, Monfardini L, Bna C, et al
    Association of mediastinal lymphadenopathy with COVID-19 prognosis.
    Lancet Infect Dis. 2020 Jun 19. pii: S1473-3099(20)30521.
    PubMed    


  95. HUBICHE T, Le Duff F, Chiaverini C, Giordanengo V, et al
    Negative SARS-CoV-2 PCR in patients with chilblain-like lesions.
    Lancet Infect Dis. 2020 Jun 18. pii: S1473-3099(20)30518.
    PubMed    


  96. PITZER VE, Cohen T
    Household studies provide key insights on the transmission of, and susceptibility to, SARS-CoV-2.
    Lancet Infect Dis. 2020 Jun 17. pii: S1473-3099(20)30514.
    PubMed    


  97. JING QL, Liu MJ, Zhang ZB, Fang LQ, et al
    Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort study.
    Lancet Infect Dis. 2020 Jun 17. pii: S1473-3099(20)30471.
    PubMed     Abstract available


  98. AFRA TP, T MR, Bishnoi A, Hafi NB, et al
    Hydroxychloroquine use in COVID-19: what is the basis for baseline tests?
    Lancet Infect Dis. 2020 Jun 16. pii: S1473-3099(20)30472.
    PubMed    


  99. MACINTYRE CR
    Case isolation, contact tracing, and physical distancing are pillars of COVID-19 pandemic control, not optional choices.
    Lancet Infect Dis. 2020 Jun 15. pii: S1473-3099(20)30512.
    PubMed    


  100. KUCHARSKI AJ, Klepac P, Conlan AJK, Kissler SM, et al
    Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study.
    Lancet Infect Dis. 2020 Jun 15. pii: S1473-3099(20)30457.
    PubMed     Abstract available


  101. TEDDER RS, Semple MG
    Appropriate selection of convalescent plasma donors for COVID-19.
    Lancet Infect Dis. 2020 Jun 15. pii: S1473-3099(20)30470.
    PubMed    


  102. NTOUMI F, Velavan TP
    COVID-19 in Africa: between hope and reality.
    Lancet Infect Dis. 2020 Jun 15. pii: S1473-3099(20)30465.
    PubMed    


  103. COX RJ, Brokstad KA, Krammer F, Langeland N, et al
    Seroconversion in household members of COVID-19 outpatients.
    Lancet Infect Dis. 2020 Jun 15. pii: S1473-3099(20)30466.
    PubMed    



  104. A minimal common outcome measure set for COVID-19 clinical research.
    Lancet Infect Dis. 2020 Jun 12. pii: S1473-3099(20)30483.
    PubMed     Abstract available


  105. OOI EE, Low JG
    Asymptomatic SARS-CoV-2 infection.
    Lancet Infect Dis. 2020 Jun 12. pii: S1473-3099(20)30460.
    PubMed    


  106. TABATA S, Imai K, Kawano S, Ikeda M, et al
    Clinical characteristics of COVID-19 in 104 people with SARS-CoV-2 infection on the Diamond Princess cruise ship: a retrospective analysis.
    Lancet Infect Dis. 2020 Jun 12. pii: S1473-3099(20)30482.
    PubMed     Abstract available


  107. HUNG IF, Cheng VC, Li X, Tam AR, et al
    SARS-CoV-2 shedding and seroconversion among passengers quarantined after disembarking a cruise ship: a case series.
    Lancet Infect Dis. 2020 Jun 12. pii: S1473-3099(20)30364.
    PubMed     Abstract available


  108. THE LANCET INFECTIOUS DISEASES
    Political casualties of the COVID-19 pandemic.
    Lancet Infect Dis. 2020 Jun 11. pii: S1473-3099(20)30496.
    PubMed    


  109. CARSANA L, Sonzogni A, Nasr A, Rossi RS, et al
    Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study.
    Lancet Infect Dis. 2020 Jun 8. pii: S1473-3099(20)30434.
    PubMed     Abstract available


  110. YI ES, Cecchini MJ, Bois MC
    Pathologists in pursuit of the COVID-19 culprit.
    Lancet Infect Dis. 2020 Jun 8. pii: S1473-3099(20)30449.
    PubMed    


  111. MCDONALD ES
    COVID-19 and essential pregnant worker policies.
    Lancet Infect Dis. 2020 Jun 2. pii: S1473-3099(20)30446.
    PubMed    


  112. EKTORP E
    Death threats after a trial on chloroquine for COVID-19.
    Lancet Infect Dis. 2020;20:661.
    PubMed    


  113. NAKKAZI E
    Obstacles to COVID-19 control in east Africa.
    Lancet Infect Dis. 2020;20:660.
    PubMed    


  114. HOLT E
    COVID-19 lockdown of Roma settlements in Slovakia.
    Lancet Infect Dis. 2020;20:659.
    PubMed    


  115. KOO JR, Cook AR, Park M, Sun Y, et al
    Interventions to mitigate early spread of SARS-CoV-2 in Singapore: a modelling study.
    Lancet Infect Dis. 2020;20:678-688.
    PubMed     Abstract available


  116. MOUSAVI SH, Shah J, Giang HTN, Al-Ahdal TMA, et al
    The first COVID-19 case in Afghanistan acquired from Iran.
    Lancet Infect Dis. 2020;20:657-658.
    PubMed    


  117. LEWNARD JA, Lo NC
    Scientific and ethical basis for social-distancing interventions against COVID-19.
    Lancet Infect Dis. 2020;20:631-633.
    PubMed    


  118. KELVIN AA, Halperin S
    COVID-19 in children: the link in the transmission chain.
    Lancet Infect Dis. 2020;20:633-634.
    PubMed    


  119. RUAN S
    Likelihood of survival of coronavirus disease 2019.
    Lancet Infect Dis. 2020;20:630-631.
    PubMed    


  120. THE LANCET INFECTIOUS DISEASES
    Riding the coronacoaster of uncertainty.
    Lancet Infect Dis. 2020;20:629.
    PubMed    


  121. HUSSAINI SMQ
    Dearth of infectious diseases physicians as the USA faces a global pandemic.
    Lancet Infect Dis. 2020;20:648-649.
    PubMed    


    May 2020
  122. JAMROZIK E, Selgelid MJ
    COVID-19 human challenge studies: ethical issues.
    Lancet Infect Dis. 2020 May 29. pii: S1473-3099(20)30438.
    PubMed     Abstract available


  123. OSORIO NS, Correia-Neves M
    Implication of SARS-CoV-2 evolution in the sensitivity of RT-qPCR diagnostic assays.
    Lancet Infect Dis. 2020 May 28. pii: S1473-3099(20)30435.
    PubMed    


  124. WOOD SN, Wit EC, Fasiolo M, Green PJ, et al
    COVID-19 and the difficulty of inferring epidemiological parameters from clinical data.
    Lancet Infect Dis. 2020 May 28. pii: S1473-3099(20)30437.
    PubMed    


  125. VERITY R, Okell L, Dorigatti I, Winskill P, et al
    COVID-19 and the difficulty of inferring epidemiological parameters from clinical data - Authors' reply.
    Lancet Infect Dis. 2020 May 28. pii: S1473-3099(20)30443.
    PubMed    


  126. TILANGI P, Desai D, Khan A, Soneja M, et al
    Hydroxychloroquine prophylaxis for high-risk COVID-19 contacts in India: a prudent approach.
    Lancet Infect Dis. 2020 May 22. pii: S1473-3099(20)30430.
    PubMed    



  127. A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation.
    Lancet Infect Dis. 2020 May 20. pii: S1473-3099(20)30426.
    PubMed    


  128. BAUCH CT, Anand M
    COVID-19: when should quarantine be enforced?
    Lancet Infect Dis. 2020 May 20. pii: S1473-3099(20)30428.
    PubMed    


  129. PEAK CM, Kahn R, Grad YH, Childs LM, et al
    Individual quarantine versus active monitoring of contacts for the mitigation of COVID-19: a modelling study.
    Lancet Infect Dis. 2020 May 20. pii: S1473-3099(20)30361.
    PubMed     Abstract available


  130. HAN MS, Byun JH, Cho Y, Rim JH, et al
    RT-PCR for SARS-CoV-2: quantitative versus qualitative.
    Lancet Infect Dis. 2020 May 20. pii: S1473-3099(20)30424.
    PubMed    


  131. MEMISH ZA, Aljerian N, Ebrahim SH
    Tale of three seeding patterns of SARS-CoV-2 in Saudi Arabia.
    Lancet Infect Dis. 2020 May 19. pii: S1473-3099(20)30425.
    PubMed    


  132. KHALIL A, Hill R, Ladhani S, Pattisson K, et al
    COVID-19 screening of health-care workers in a London maternity hospital.
    Lancet Infect Dis. 2020 May 18. pii: S1473-3099(20)30403.
    PubMed    


  133. GUARNERI C, Rullo EV, Pavone P, Berretta M, et al
    Silent COVID-19: what your skin can reveal.
    Lancet Infect Dis. 2020 May 18. pii: S1473-3099(20)30402.
    PubMed    


  134. BUONSENSO D, Parri N, De Rose C, Valentini P, et al
    Toward a clinically based classification of disease severity for paediatric COVID-19.
    Lancet Infect Dis. 2020 May 15. pii: S1473-3099(20)30396.
    PubMed    


  135. DE LUSIGNAN S, Dorward J, Correa A, Jones N, et al
    Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study.
    Lancet Infect Dis. 2020 May 15. pii: S1473-3099(20)30371.
    PubMed     Abstract available


  136. BOHMER MM, Buchholz U, Corman VM, Hoch M, et al
    Investigation of a COVID-19 outbreak in Germany resulting from a single travel-associated primary case: a case series.
    Lancet Infect Dis. 2020 May 15. pii: S1473-3099(20)30314.
    PubMed     Abstract available


  137. CHEN D, Tang F, Lu S, Song Q, et al
    Toward a clinically based classification of disease severity for paediatric COVID-19 - Authors' reply.
    Lancet Infect Dis. 2020 May 15. pii: S1473-3099(20)30397.
    PubMed    


  138. SIMPSON CR, Thomas BD, Challen K, De Angelis D, et al
    The UK hibernated pandemic influenza research portfolio: triggered for COVID-19.
    Lancet Infect Dis. 2020 May 15. pii: S1473-3099(20)30398.
    PubMed    


  139. RYBNIKER J, Fatkenheuer G
    Importance of precise data on SARS-CoV-2 transmission dynamics control.
    Lancet Infect Dis. 2020 May 15. pii: S1473-3099(20)30359.
    PubMed    


  140. JORDAN RE, Adab P
    Who is most likely to be infected with SARS-CoV-2?
    Lancet Infect Dis. 2020 May 15. pii: S1473-3099(20)30395.
    PubMed    


  141. WRIGHT DJM
    Prevention of the cytokine storm in COVID-19.
    Lancet Infect Dis. 2020 May 7. pii: S1473-3099(20)30376.
    PubMed    


  142. LIPSITCH M, Perlman S, Waldor MK
    Testing COVID-19 therapies to prevent progression of mild disease.
    Lancet Infect Dis. 2020 May 6. pii: S1473-3099(20)30372.
    PubMed    


  143. WELLS CR, Stearns JK, Lutumba P, Galvani AP, et al
    COVID-19 on the African continent.
    Lancet Infect Dis. 2020 May 6. pii: S1473-3099(20)30374.
    PubMed    


  144. MBOPI-KEOU FX, Pondi JE, Sosso MA
    COVID-19 in Cameroon: a crucial equation to resolve.
    Lancet Infect Dis. 2020 May 6. pii: S1473-3099(20)30373.
    PubMed    


  145. CHETTERJE P
    Gaps in India's preparedness for COVID-19 control.
    Lancet Infect Dis. 2020;20:544.
    PubMed    


  146. RANSCOMBE P
    Rural areas at risk during COVID-19 pandemic.
    Lancet Infect Dis. 2020;20:545.
    PubMed    


  147. THE LANCET INFECTIOUS DISEASES
    COVID-19: endgames.
    Lancet Infect Dis. 2020;20:511.
    PubMed    


  148. BURKI T
    COVID-19 in Latin America.
    Lancet Infect Dis. 2020;20:547-548.
    PubMed    


  149. TO KK, Tsang OT, Leung WS, Tam AR, et al
    Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study.
    Lancet Infect Dis. 2020;20:565-574.
    PubMed     Abstract available


  150. CHEN Y, Li L
    SARS-CoV-2: virus dynamics and host response.
    Lancet Infect Dis. 2020;20:515-516.
    PubMed    


  151. MCBRYDE E
    The value of early transmission dynamic studies in emerging infectious diseases.
    Lancet Infect Dis. 2020;20:512-513.
    PubMed    


  152. SIMPSON S, Kaufmann MC, Glozman V, Chakrabarti A, et al
    Disease X: accelerating the development of medical countermeasures for the next pandemic.
    Lancet Infect Dis. 2020;20:e108-e115.
    PubMed     Abstract available


    April 2020
  153. LANG M, Som A, Mendoza DP, Flores EJ, et al
    Hypoxaemia related to COVID-19: vascular and perfusion abnormalities on dual-energy CT.
    Lancet Infect Dis. 2020 Apr 30. pii: S1473-3099(20)30367.
    PubMed    


  154. ENDEMAN H, van der Zee P, van Genderen ME, van den Akker JPC, et al
    Progressive respiratory failure in COVID-19: a hypothesis.
    Lancet Infect Dis. 2020 Apr 29. pii: S1473-3099(20)30366.
    PubMed    


  155. LOHSE S, Pfuhl T, Berko-Gottel B, Rissland J, et al
    Pooling of samples for testing for SARS-CoV-2 in asymptomatic people.
    Lancet Infect Dis. 2020 Apr 28. pii: S1473-3099(20)30362.
    PubMed    


  156. SUN K, Viboud C
    Impact of contact tracing on SARS-CoV-2 transmission.
    Lancet Infect Dis. 2020 Apr 27. pii: S1473-3099(20)30357.
    PubMed    


  157. NEGIDA A
    Estimation of COVID-19 burden in Egypt.
    Lancet Infect Dis. 2020 Apr 27. pii: S1473-3099(20)30329.
    PubMed    


  158. SAHMOUD T
    Estimation of COVID-19 burden in Egypt.
    Lancet Infect Dis. 2020 Apr 27. pii: S1473-3099(20)30318.
    PubMed    


  159. BI Q, Wu Y, Mei S, Ye C, et al
    Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study.
    Lancet Infect Dis. 2020 Apr 27. pii: S1473-3099(20)30287.
    PubMed     Abstract available


  160. HASSANY M, Abdel-Razek W, Asem N, AbdAllah M, et al
    Estimation of COVID-19 burden in Egypt.
    Lancet Infect Dis. 2020 Apr 27. pii: S1473-3099(20)30319.
    PubMed    


  161. ELMELEEGY K
    Estimation of COVID-19 burden in Egypt.
    Lancet Infect Dis. 2020 Apr 27. pii: S1473-3099(20)30321.
    PubMed    


  162. TUITE AR, Ng V, Rees E, Fisman D, et al
    Estimation of COVID-19 burden in Egypt - Authors' reply.
    Lancet Infect Dis. 2020 Apr 27. pii: S1473-3099(20)30326.
    PubMed    


  163. YU N, Li W, Kang Q, Zeng W, et al
    No SARS-CoV-2 detected in amniotic fluid in mid-pregnancy.
    Lancet Infect Dis. 2020 Apr 22. pii: S1473-3099(20)30320.
    PubMed    


  164. WINTER AK, Hegde ST
    The important role of serology for COVID-19 control.
    Lancet Infect Dis. 2020 Apr 21. pii: S1473-3099(20)30322.
    PubMed    


  165. VALETTE X, du Cheyron D, Goursaud S
    Mediastinal lymphadenopathy in patients with severe COVID-19.
    Lancet Infect Dis. 2020 Apr 21. pii: S1473-3099(20)30310.
    PubMed    


  166. YONG SEF, Anderson DE, Wei WE, Pang J, et al
    Connecting clusters of COVID-19: an epidemiological and serological investigation.
    Lancet Infect Dis. 2020 Apr 21. pii: S1473-3099(20)30273.
    PubMed     Abstract available


  167. HARGREAVES S, Zenner D, Wickramage K, Deal A, et al
    Targeting COVID-19 interventions towards migrants in humanitarian settings.
    Lancet Infect Dis. 2020 Apr 21. pii: S1473-3099(20)30292.
    PubMed    


  168. WELLS CR, Fitzpatrick MC, Sah P, Shoukat A, et al
    Projecting the demand for ventilators at the peak of the COVID-19 outbreak in the USA.
    Lancet Infect Dis. 2020 Apr 20. pii: S1473-3099(20)30315.
    PubMed    


  169. GABORIT BJ, Bergmann JF, Mussini C, Arribas JR, et al
    Plea for multitargeted interventions for severe COVID-19.
    Lancet Infect Dis. 2020 Apr 20. pii: S1473-3099(20)30312.
    PubMed    


  170. MODJARRAD K, Kim JH
    Two Middle East respiratory syndrome vaccines: first step for other coronavirus vaccines?
    Lancet Infect Dis. 2020 Apr 20. pii: S1473-3099(20)30317.
    PubMed    


  171. FOLEGATTI PM, Bittaye M, Flaxman A, Lopez FR, et al
    Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial.
    Lancet Infect Dis. 2020 Apr 20. pii: S1473-3099(20)30160.
    PubMed     Abstract available


  172. KOCH T, Dahlke C, Fathi A, Kupke A, et al
    Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial.
    Lancet Infect Dis. 2020 Apr 20. pii: S1473-3099(20)30248.
    PubMed     Abstract available


  173. NELSON R
    COVID-19 disrupts vaccine delivery.
    Lancet Infect Dis. 2020 Apr 17. pii: S1473-3099(20)30304.
    PubMed    


  174. GLYNN JR
    Protecting workers aged 60-69 years from COVID-19.
    Lancet Infect Dis. 2020 Apr 16. pii: S1473-3099(20)30311.
    PubMed    


  175. BENEZIT F, Le Turnier P, Declerck C, Paille C, et al
    Utility of hyposmia and hypogeusia for the diagnosis of COVID-19.
    Lancet Infect Dis. 2020 Apr 15. pii: S1473-3099(20)30297.
    PubMed    


  176. MEYER JP, Franco-Paredes C, Parmar P, Yasin F, et al
    COVID-19 and the coming epidemic in US immigration detention centres.
    Lancet Infect Dis. 2020 Apr 15. pii: S1473-3099(20)30295.
    PubMed    


  177. XYDAKIS MS, Dehgani-Mobaraki P, Holbrook EH, Geisthoff UW, et al
    Smell and taste dysfunction in patients with COVID-19.
    Lancet Infect Dis. 2020 Apr 15. pii: S1473-3099(20)30293.
    PubMed    


  178. MARTINEZ-PORTILLA RJ, Gonce A, Hawkins-Villarreal A, Figueras F, et al
    A Spanish-translated clinical algorithm for management of suspected SARS-CoV-2 infection in pregnant women.
    Lancet Infect Dis. 2020 Apr 9. pii: S1473-3099(20)30285.
    PubMed    


  179. KUCHARSKI AJ, Eggo RM
    Invisible spread of SARS-CoV-2 - Authors' reply.
    Lancet Infect Dis. 2020 Apr 7. pii: S1473-3099(20)30275.
    PubMed    


  180. ZHANG W, Qian BY
    Making decisions to mitigate COVID-19 with limited knowledge.
    Lancet Infect Dis. 2020 Apr 7. pii: S1473-3099(20)30280.
    PubMed    


  181. XIONG N, Wang T, Lin Z
    Invisible spread of SARS-CoV-2.
    Lancet Infect Dis. 2020 Apr 7. pii: S1473-3099(20)30263.
    PubMed    


  182. RICHARDSON PJ, Corbellino M, Stebbing J
    Baricitinib for COVID-19: a suitable treatment? - Authors' reply.
    Lancet Infect Dis. 2020 Apr 3. pii: S1473-3099(20)30270.
    PubMed    


  183. FAVALLI EG, Biggioggero M, Maioli G, Caporali R, et al
    Baricitinib for COVID-19: a suitable treatment?
    Lancet Infect Dis. 2020 Apr 3. pii: S1473-3099(20)30262.
    PubMed    


  184. DEVI S
    US public health budget cuts in the face of COVID-19.
    Lancet Infect Dis. 2020;20:415.
    PubMed    


    March 2020
  185. POLAND GA
    SARS-CoV-2: a time for clear and immediate action.
    Lancet Infect Dis. 2020 Mar 31. pii: S1473-3099(20)30250.
    PubMed    


  186. SPYCHALSKI P, Blazynska-Spychalska A, Kobiela J
    Estimating case fatality rates of COVID-19.
    Lancet Infect Dis. 2020 Mar 31. pii: S1473-3099(20)30246.
    PubMed    


  187. KIM DD, Goel A
    Estimating case fatality rates of COVID-19.
    Lancet Infect Dis. 2020 Mar 31. pii: S1473-3099(20)30234.
    PubMed    


  188. LIPSITCH M
    Estimating case fatality rates of COVID-19.
    Lancet Infect Dis. 2020 Mar 31. pii: S1473-3099(20)30245.
    PubMed    


  189. VERITY R, Okell LC, Dorigatti I, Winskill P, et al
    Estimates of the severity of coronavirus disease 2019: a model-based analysis.
    Lancet Infect Dis. 2020 Mar 30. pii: S1473-3099(20)30243.
    PubMed     Abstract available


  190. RAJGOR DD, Lee MH, Archuleta S, Bagdasarian N, et al
    The many estimates of the COVID-19 case fatality rate.
    Lancet Infect Dis. 2020 Mar 27. pii: S1473-3099(20)30244.
    PubMed    


  191. LESCURE FX, Bouadma L, Nguyen D, Parisey M, et al
    Clinical and virological data of the first cases of COVID-19 in Europe: a case series.
    Lancet Infect Dis. 2020 Mar 27. pii: S1473-3099(20)30200.
    PubMed     Abstract available


  192. JOYNT GM, Wu WK
    Understanding COVID-19: what does viral RNA load really mean?
    Lancet Infect Dis. 2020 Mar 27. pii: S1473-3099(20)30237.
    PubMed    


  193. HUANG Y, Cheng W, Zhao N, Qu H, et al
    CT screening for early diagnosis of SARS-CoV-2 infection.
    Lancet Infect Dis. 2020 Mar 26. pii: S1473-3099(20)30241.
    PubMed    


  194. SHI H, Han X, Cao Y, Alwalid O, et al
    CT screening for early diagnosis of SARS-CoV-2 infection - Authors' reply.
    Lancet Infect Dis. 2020 Mar 26. pii: S1473-3099(20)30247.
    PubMed    


  195. TUITE AR, Ng V, Rees E, Fisman D, et al
    Estimation of the COVID-19 burden in Egypt through exported case detection.
    Lancet Infect Dis. 2020 Mar 26. pii: S1473-3099(20)30233.
    PubMed    


  196. QIU H, Wu J, Hong L, Luo Y, et al
    Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study.
    Lancet Infect Dis. 2020 Mar 25. pii: S1473-3099(20)30198.
    PubMed     Abstract available


  197. LUO Y, Yin K
    Management of pregnant women infected with COVID-19.
    Lancet Infect Dis. 2020 Mar 24. pii: S1473-3099(20)30191.
    PubMed    


  198. YU N, Li W, Kang Q, Xiong Z, et al
    Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-centre, descriptive study.
    Lancet Infect Dis. 2020 Mar 24. pii: S1473-3099(20)30176.
    PubMed     Abstract available


  199. TUITE AR, Ng V, Rees E, Fisman D, et al
    Estimation of COVID-19 outbreak size in Italy.
    Lancet Infect Dis. 2020 Mar 19. pii: S1473-3099(20)30227.
    PubMed    


  200. LIU Y, Yan LM, Wan L, Xiang TX, et al
    Viral dynamics in mild and severe cases of COVID-19.
    Lancet Infect Dis. 2020 Mar 19. pii: S1473-3099(20)30232.
    PubMed    


  201. SCHMID MB, Fontijn J, Ochsenbein-Kolble N, Berger C, et al
    COVID-19 in pregnant women.
    Lancet Infect Dis. 2020 Mar 17. pii: S1473-3099(20)30175.
    PubMed    


  202. BAUD D, Giannoni E, Pomar L, Qi X, et al
    COVID-19 in pregnant women - Authors' reply.
    Lancet Infect Dis. 2020 Mar 17. pii: S1473-3099(20)30192.
    PubMed    


  203. THE LANCET INFECTIOUS DISEASES
    COVID-19, a pandemic or not?
    Lancet Infect Dis. 2020 Mar 13. pii: S1473-3099(20)30180.
    PubMed    


  204. BAUD D, Qi X, Nielsen-Saines K, Musso D, et al
    Real estimates of mortality following COVID-19 infection.
    Lancet Infect Dis. 2020 Mar 12. pii: S1473-3099(20)30195.
    PubMed    


  205. HAN H, Luo Q, Mo F, Long L, et al
    SARS-CoV-2 RNA more readily detected in induced sputum than in throat swabs of convalescent COVID-19 patients.
    Lancet Infect Dis. 2020 Mar 12. pii: S1473-3099(20)30174.
    PubMed    


  206. KUCHARSKI AJ, Russell TW, Diamond C, Liu Y, et al
    Early dynamics of transmission and control of COVID-19: a mathematical modelling study.
    Lancet Infect Dis. 2020 Mar 11. pii: S1473-3099(20)30144.
    PubMed     Abstract available


  207. ZHOU C, Gao C, Xie Y, Xu M, et al
    COVID-19 with spontaneous pneumomediastinum.
    Lancet Infect Dis. 2020 Mar 9. pii: S1473-3099(20)30156.
    PubMed    


  208. WILDER-SMITH A, Chiew CJ, Lee VJ
    Can we contain the COVID-19 outbreak with the same measures as for SARS?
    Lancet Infect Dis. 2020 Mar 5. pii: S1473-3099(20)30129.
    PubMed     Abstract available


  209. XIAO Y, Torok ME
    Taking the right measures to control COVID-19.
    Lancet Infect Dis. 2020 Mar 5. pii: S1473-3099(20)30152.
    PubMed    


  210. YAN G, Lee CK, Lam LTM, Yan B, et al
    Covert COVID-19 and false-positive dengue serology in Singapore.
    Lancet Infect Dis. 2020 Mar 4. pii: S1473-3099(20)30158.
    PubMed    


  211. THANH HN, Van TN, Thu HNT, Van BN, et al
    Outbreak investigation for COVID-19 in northern Vietnam.
    Lancet Infect Dis. 2020 Mar 4. pii: S1473-3099(20)30159.
    PubMed    


  212. FAVRE G, Pomar L, Qi X, Nielsen-Saines K, et al
    Guidelines for pregnant women with suspected SARS-CoV-2 infection.
    Lancet Infect Dis. 2020 Mar 3. pii: S1473-3099(20)30157.
    PubMed    


  213. THE LANCET INFECTIOUS DISEASES
    Challenges of coronavirus disease 2019.
    Lancet Infect Dis. 2020;20:261.
    PubMed    


  214. BURKI T
    Outbreak of coronavirus disease 2019.
    Lancet Infect Dis. 2020;20:292-293.
    PubMed    


  215. BASTOLA A, Sah R, Rodriguez-Morales AJ, Lal BK, et al
    The first 2019 novel coronavirus case in Nepal.
    Lancet Infect Dis. 2020;20:279-280.
    PubMed    


  216. LI J, Li JJ, Xie X, Cai X, et al
    Game consumption and the 2019 novel coronavirus.
    Lancet Infect Dis. 2020;20:275-276.
    PubMed    


    February 2020
  217. HUANG R, Xia J, Chen Y, Shan C, et al
    A family cluster of SARS-CoV-2 infection involving 11 patients in Nanjing, China.
    Lancet Infect Dis. 2020 Feb 28. pii: S1473-3099(20)30147.
    PubMed    


  218. CHEN L, Xiong J, Bao L, Shi Y, et al
    Convalescent plasma as a potential therapy for COVID-19.
    Lancet Infect Dis. 2020 Feb 27. pii: S1473-3099(20)30141.
    PubMed    


  219. STEBBING J, Phelan A, Griffin I, Tucker C, et al
    COVID-19: combining antiviral and anti-inflammatory treatments.
    Lancet Infect Dis. 2020 Feb 27. pii: S1473-3099(20)30132.
    PubMed    


  220. LEE EYP, Ng MY, Khong PL
    COVID-19 pneumonia: what has CT taught us?
    Lancet Infect Dis. 2020 Feb 24. pii: S1473-3099(20)30134.
    PubMed    


  221. PAN Y, Zhang D, Yang P, Poon LLM, et al
    Viral load of SARS-CoV-2 in clinical samples.
    Lancet Infect Dis. 2020 Feb 24. pii: S1473-3099(20)30113.
    PubMed    


  222. SHI H, Han X, Jiang N, Cao Y, et al
    Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study.
    Lancet Infect Dis. 2020 Feb 24. pii: S1473-3099(20)30086.
    PubMed     Abstract available


  223. PAN X, Chen D, Xia Y, Wu X, et al
    Asymptomatic cases in a family cluster with SARS-CoV-2 infection.
    Lancet Infect Dis. 2020 Feb 19. pii: S1473-3099(20)30114.
    PubMed    


  224. XU B, Kraemer MUG
    Open access epidemiological data from the COVID-19 outbreak.
    Lancet Infect Dis. 2020 Feb 19. pii: S1473-3099(20)30119.
    PubMed    


  225. DONG E, Du H, Gardner L
    An interactive web-based dashboard to track COVID-19 in real time.
    Lancet Infect Dis. 2020 Feb 19. pii: S1473-3099(20)30120.
    PubMed    


  226. CHEN X, Tian J, Li G, Li G, et al
    Initiation of a new infection control system for the COVID-19 outbreak.
    Lancet Infect Dis. 2020 Feb 18. pii: S1473-3099(20)30110.
    PubMed    


  227. VAN CUONG L, Giang HTN, Linh LK, Shah J, et al
    The first Vietnamese case of COVID-19 acquired from China.
    Lancet Infect Dis. 2020 Feb 18. pii: S1473-3099(20)30111.
    PubMed    


  228. THOMPSON R
    Pandemic potential of 2019-nCoV.
    Lancet Infect Dis. 2020 Feb 7. pii: S1473-3099(20)30068.
    PubMed    


  229. BAGCCHI S
    Mysterious pneumonia in China.
    Lancet Infect Dis. 2020;20:173.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO COVID-19 is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: